Previous Article | Next Article ![]()
Molecular and Cellular Biology, July 2002, p. 4556-4566, Vol. 22, No. 13
0270-7306/02/$04.00+0 DOI: 10.1128/MCB.22.13.4556-4566.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Institute of Molecular Biology, Academia Sinica,1 Graduate Institute of Life Science, National Defense Medical School,2 Division of Molecular & Genomic Medicine, National Health Research Institute,3 Institute of Microbiology and Immunology, National Yang-Ming University, Taipei, Taiwan, Republic of China4
Received 11 February 2002/ Returned for modification 18 March 2002/ Accepted 1 April 2002
Positive selection of T cells is postulated to be dependent on the counterinteraction between glucocorticoid receptor (GR)- and T-cell-receptor (TCR)-induced death signals. In this study we used T-cell-specific expression of p300 to investigate whether GR-TCR cross talk between thymocytes was affected. Activation of the p300-transgenic T cells led to enhanced thymocyte proliferation and increased interleukin 2 production. Thymocyte death, induced by TCR engagement, was no longer prevented by dexamethasone in p300-transgenic mice, indicating an absence of GR-TCR cross-inhibition. This was accompanied by a 50% reduction in the number of thymocytes in p300-transgenic mice. However, the CD4/CD8 profile of thymocytes remained unchanged in p300-transgenic mice. There was no effect on positive selection of the bulk thymocytes or thymocytes with transgenic TCR in p300-transgenic mice. In addition, there was no apparent TCR repertoire "hole" in the selected antigens examined. Our results illustrate a critical role of CBP/p300 in thymic GR-TCR counterinteraction yet do not support the involvement of GR-TCR antagonism in thymocyte positive selection.
This article has been cited by other articles:
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»